Maravai LifeSciences Holdings, Inc. Proceeds from (Payments for) Other Financing Activities
Maravai LifeSciences Holdings, Inc. (MRVI) reported Proceeds from (Payments for) Other Financing Activities of -$455.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2026-06-30 was $3.41M, a 24.95% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2026-03-31 was -$3.87M.
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2025-06-30 was $4.54M.
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for the quarter ending 2025-03-31 was -$3.54M.
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for fiscal 2025 was -$5.64M.
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for fiscal 2024 was -$1.76M.
- Maravai LifeSciences Holdings, Inc. proceeds from (payments for) other financing activities for fiscal 2023 was -$352.00K.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|---|---|
| 2026-06-30 | $3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$455.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | -$3.87M 10-Q · filed 2026-05-08 | ||
| 2025-12-31 | -$5.64M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.00M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | -$3.54M 10-Q · filed 2026-05-08 | ||
| 2024-12-31 | -$1.76M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | -$352.00K 10-K · filed 2026-02-26 |